349 related articles for article (PubMed ID: 30393955)
1. Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.
Itoh H; Komuro I; Takeuchi M; Akasaka T; Daida H; Egashira Y; Fujita H; Higaki J; Hirata KI; Ishibashi S; Isshiki T; Ito S; Kashiwagi A; Kato S; Kitagawa K; Kitakaze M; Kitazono T; Kurabayashi M; Miyauchi K; Murakami T; Murohara T; Node K; Ogawa S; Saito Y; Seino Y; Shigeeda T; Shindo S; Sugawara M; Sugiyama S; Terauchi Y; Tsutsui H; Ueshima K; Utsunomiya K; Yamagishi M; Yamazaki T; Yo S; Yokote K; Yoshida K; Yoshimura M; Yoshimura N; Nakao K; Nagai R;
Diabetes Obes Metab; 2019 Apr; 21(4):791-800. PubMed ID: 30393955
[TBL] [Abstract][Full Text] [Related]
2. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.
Itoh H; Komuro I; Takeuchi M; Akasaka T; Daida H; Egashira Y; Fujita H; Higaki J; Hirata KI; Ishibashi S; Isshiki T; Ito S; Kashiwagi A; Kato S; Kitagawa K; Kitakaze M; Kitazono T; Kurabayashi M; Miyauchi K; Murakami T; Murohara T; Node K; Ogawa S; Saito Y; Seino Y; Shigeeda T; Shindo S; Sugawara M; Sugiyama S; Terauchi Y; Tsutsui H; Ueshima K; Utsunomiya K; Yamagishi M; Yamazaki T; Yo S; Yokote K; Yoshida K; Yoshimura M; Yoshimura N; Nakao K; Nagai R;
Diabetes Care; 2018 Jun; 41(6):1275-1284. PubMed ID: 29626074
[TBL] [Abstract][Full Text] [Related]
3. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.
Fung CSC; Wan EYF; Chan AKC; Lam CLK
BMC Cardiovasc Disord; 2017 Jun; 17(1):166. PubMed ID: 28645252
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
Hagiwara N; Kawada-Watanabe E; Koyanagi R; Arashi H; Yamaguchi J; Nakao K; Tobaru T; Tanaka H; Oka T; Endoh Y; Saito K; Uchida T; Matsui K; Ogawa H
Eur Heart J; 2017 Aug; 38(29):2264-2276. PubMed ID: 28430910
[TBL] [Abstract][Full Text] [Related]
5. Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial.
Ueshima K; Itoh H; Kanazawa N; Komuro I; Nagai R; Takeuchi M; Yamazaki T;
J Atheroscler Thromb; 2016 Aug; 23(8):976-90. PubMed ID: 26961114
[TBL] [Abstract][Full Text] [Related]
6. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
[TBL] [Abstract][Full Text] [Related]
7. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
Amarenco P; Kim JS; Labreuche J; Charles H; Abtan J; Béjot Y; Cabrejo L; Cha JK; Ducrocq G; Giroud M; Guidoux C; Hobeanu C; Kim YJ; Lapergue B; Lavallée PC; Lee BC; Lee KB; Leys D; Mahagne MH; Meseguer E; Nighoghossian N; Pico F; Samson Y; Sibon I; Steg PG; Sung SM; Touboul PJ; Touzé E; Varenne O; Vicaut É; Yelles N; Bruckert E;
N Engl J Med; 2020 Jan; 382(1):9. PubMed ID: 31738483
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial.
Hall AS; Jackson BM; Farrin AJ; Efthymiou M; Barth JH; Copeland J; Bailey KM; Romaine SP; Balmforth AJ; McCormack T; Whitehead A; Flather MD; Nixon J;
Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):712-21. PubMed ID: 19745745
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of statin intensive therapy in type 2 diabetes mellitus with high visit-to-visit blood pressure variability.
Ikeda S; Shinohara K; Enzan N; Matsushima S; Tohyama T; Funakoshi K; Kishimoto J; Itoh H; Komuro I; Tsutsui H
J Hypertens; 2021 Jul; 39(7):1435-1443. PubMed ID: 34001809
[TBL] [Abstract][Full Text] [Related]
11. Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study.
Wan EYF; Xu W; Mok AHY; Chin WY; Yu EYT; Chui CSL; Chan EWY; Wong ICK; Lam CLK; Danaei G
Diabetes Obes Metab; 2024 May; 26(5):1877-1887. PubMed ID: 38379445
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intensive lipid-lowering therapy with statins stratified by blood pressure levels in patients with type 2 diabetes mellitus and retinopathy: Insight from the EMPATHY study.
Shinohara K; Ikeda S; Enzan N; Matsushima S; Tohyama T; Funakoshi K; Kishimoto J; Itoh H; Komuro I; Tsutsui H
Hypertens Res; 2021 Dec; 44(12):1606-1616. PubMed ID: 34526672
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study.
Ardigò D; Vaccaro O; Cavalot F; Rivellese AA; Franzini L; Miccoli R; Patti L; Boemi M; Trovati M; Zavaroni I;
Eur J Prev Cardiol; 2014 Apr; 21(4):456-63. PubMed ID: 23147277
[TBL] [Abstract][Full Text] [Related]
14. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
15. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
[TBL] [Abstract][Full Text] [Related]
16. Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).
Hosomi N; Kitagawa K; Nagai Y; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
Stroke; 2018 Apr; 49(4):865-871. PubMed ID: 29511130
[TBL] [Abstract][Full Text] [Related]
17. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
[TBL] [Abstract][Full Text] [Related]
18. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N
J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis.
An J; Alemao E; Reynolds K; Kawabata H; Solomon DH; Liao KP; Niu F; Cheetham TC
J Rheumatol; 2016 Nov; 43(11):1989-1996. PubMed ID: 27585690
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin: clinical effects from the LIVES Study.
Teramoto T
Atheroscler Suppl; 2011 Nov; 12(3):285-8. PubMed ID: 22152283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
